HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Givenchy

This article was originally published in The Rose Sheet

Executive Summary

Teint Ecran Compact Foundation Cream SPF 15 offers light, natural coverage in five shades, such as Nature, Rose Pur and Sable, and is suitable for all skin types. The foundation promises to help "slow down the signs of aging by offering optimum protection" with an "anti-pollution complex" of vitamins A and E to neutralize free radicals and protect skin from environmental assaults, such as sun damage, Givenchy said. Hyaluronic acid is added to moisturize, spherical polymers reduce shine and a light-reflecting complex minimizes the appearances of wrinkles, fine lines and tired skin. Teint Ecran, housed in a .4 oz. black Givenchy signature compact, retails for $42 and will be available at all Givenchy counters in November

You may also be interested in...



OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review
UsernamePublicRestriction

Register

RS005843

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel